Background-Fibrous
U ntil recently, atherosclerosis was considered a progressive disease that ultimately led to "hydraulic" failure. We now have sufficient evidence to consider atherosclerosis a chronic inflammatory disease that leads to an acute clinical event through plaque rupture and thrombosis, rather than an inevitable degenerative process as a consequence of aging. A new concept, which first emerged in acute coronary syndromes, is that of the "unstable" or "vulnerable" atherosclerotic plaque. 1 The frequency of unstable atheroma may be underestimated and their presentation is variable, ranging from erosion to fissure and rupture with focal defects of large areas. Nowadays, cardiologists attribute acute coronary syndromes to rupture of lipid-laden atheroma with thin fibrous caps (FCs), because most of these plaques are not hemodynamically significant before rupture. 1 The concept of atheroma instability is currently applied in neurology to explain artery-to-artery embolism that originates from the internal carotid artery (ICA). 2 On histological examination, 3 occluding thrombi have been found in the carotid arteries in the absence of plaques that cause flowlimiting stenosis. In patients dying after acute ischemic stroke, the presence of thrombus in the ICAs is associated with carotid plaque rupture, a thin FC, and inflammation. 4 -6 In other series, 7, 8 patients with symptomatic ICA stenosis had a higher frequency of plaque rupture, FC thinning, and FC foam-cell infiltration compared with the asymptomatic group.
Up to now, in vivo diagnosis of FC thinning in symptomatic patients with ICA stenosis was not possible. Such an approach requires an imaging technique that is noninvasive and reliable, allows regular control to assess the evolution of atherosclerotic carotid plaques, and is relatively inexpensive. Noninvasive techniques for the assessment of arterial wall pathology, such as CT angiography 9 and MRI, 10 are under evaluation. Developments in ultrasound such as highresolution B-mode imaging, compounded imaging, measurement of shear stress, characterization of plaque motion, and 4D color Doppler flow imaging are promising diagnostic tools for carotid wall disease. 11 We evaluated the feasibility of measuring the FC thickness (FCT) of stenosing ICA plaques with a new semiautomated ultrasound system and investigated whether the obtained values could be used to discriminate symptomatic from asymptomatic atheromata.
Methods

Study Design
We validated our method in 22 patients with ICA stenosis (9 symptomatic patients) who underwent carotid endarterectomy by comparing FCT values obtained preoperatively by ultrasound with those measured on the endarterectomy specimens. The neuropathologist (JAL) was blinded to clinical and ultrasound data. Two investigators (GD, OC), blinded to each other's results, performed separate ultrasound measurements 24 hours before surgery on each of the 20 patients. One week before surgery, one of the investigators (GD) performed measurements for each patient for which FCT values were stored but were not accessible to the examiner during or after the examination. An experienced technologist who had never performed FCT measurements was trained and subsequently performed FCT assessment (steps 2 to 4 below) based on the cineloops (step 1) acquired previously by the investigators from the same 20 patients.
We subsequently recruited consecutive patients with transient ischemic attack or ischemic stroke who were admitted to our department and in whom ultrasound examination within 12 hours after admission showed Ͼ70% ipsilateral ICA stenosis. The control group consisted of subjects who underwent exploration for carotid bruits, preoperative screening for heart surgery, or screening for cerebrovascular risk factors, in whom asymptomatic Ͼ70% ICA stenosis was found. The degree of ICA stenosis was assessed according to established criteria 12 and was always confirmed by magnetic resonance angiography. Patients with ICA occlusion detected by both ultrasound and magnetic resonance angiography were excluded from the study. All ultrasound investigations were performed by 2 authors (GD, TK). Raw data were saved, and 3 months after the end of the recruitment period, data were processed and FCT was evaluated by 2 authors (GD, OC) blinded to the history of the patient and to each other. To ensure blindness, raw data obtained by GD were subsequently processed by OC, whereas data obtained by TK were processed by GD. The study was approved by the review committee of our institution, and all subjects gave informed consent.
Histology
Endarterectomy specimens were obtained after surgery and fixed in 4% buffered formalin solution. The entire stenotic region located at the bifurcation and the proximal ICA was then decalcified to facilitate specimen sectioning. Subsequently, 3-to 4-mm-thick transverse segments were cut and embedded in paraffin blocks. Two or 3 blocks were obtained for each specimen. From these blocks, a total of 1016 (mean 51, range 31 to 88) transverse histological sections 250 m thick were obtained and stained with hematoxylineosin and elastica van Gieson. Sections within the site of tightest arterial stenosis were digitized and used for FCT measurement (Figure 1) . A total of 247 sections from 20 patients were digitized (mean 18, range 9 to 25). FCT measurements were performed with a simple length-measurement computer system. Measurements were taken at regular intervals ranging from 150 to 200 m and were restricted to regions with clear demarcation of the FC-lipid core interface. For each section, 3 to 10 FCT measurements were performed ( Figure 1 ). The number of FTC measurements fluctuated for each section due to the complex morphology of carotid atherosclerotic plaques (size, shape, and demarcation of the FC-lipid core interface differed substantially among cases). The total number of FCT measurements per specimen ranged from 9 to 198 (mean 115). For each section, a minimal, maximal, and mean value was obtained. The arithmetic mean of the minimal values obtained from each section for a given specimen was considered the minimal FCT for the patient. The same method was applied for the maximal FCT. Finally, the arithmetic mean of all measures for every specimen was obtained.
Ultrasound Technology
In each patient, we performed high-resolution B-mode imaging, color Duplex flow imaging (CDFI), and power Duplex imaging using an ATL 5000 Advanced ultrasound instrument (Phillips Medical Systems SA) equipped with a large broadband linear probe of 5 to 12 MHz, which has an axial resolution of 300 m and a lateral resolution of 400 m. The procedure to explore the FC was very strict and consisted of 4 steps. In the first step, the sonographer saved a cineloop that contained 150 to 200 frames that documented the atherosclerotic plaque responsible for the ICA stenosis. The cineloop was then transferred to a personal computer equipped with software (HDI Laboratory, Phillips Medical Systems SA) capable of analyzing each of the frames saved. In the second step, the sonographer selected the CDFI frame that best demonstrated the ICA stenosis and the residual arterial lumen (Figure 2A ). The third step consisted of working on the same frame selected previously, but this time in high-definition B-mode ( Figure 2B ), because in this mode, we obtain far better resolution than in CDFI, and because in CDFI, the FC is frequently obscured by the "blooming artifact." The fourth step consisted of a semiautomated computational procedure to measure FCT.
Ultrasound System for the Measurement of FCT
The FC was defined as a hyperechogenic structure that on CDFI and high-resolution B-mode imaging displayed stronger echoes than the atheromatous carotid plaque on contact with the circulating blood (anechogenic). 11 The FC covered an area of weaker echoes that corresponded to lipid accumulation (lipid core). We have developed a system that finds the 2 paths within a specified area that best follow the hypoechogenic-hyperechogenic and hyperechogenichypoechogenic boundaries and then measures the distance between them ( Figure 2C ). The user defines 2 points that specify the exact horizontal location of the paths and the approximate vertical location of the FC. Two boundaries are then detected automatically as the optimal path between the 2 markers with respect to intensity gradient and smoothness. The boundary facing the arterial lumen marks the calculated transition from the hypoechogenic to the hyperechogenic region; the boundary facing the lipid core marks the calculated transition from the hyperechogenic to the hypoechogenic region. If the user is not satisfied with the results, manual corrections can be made by inserting additional restriction points to change the direction of the paths ( Figure 2D ). Finally, the thickness, defined as the structure between these 2 echogenic lines, is calculated pixel by pixel along the restriction points, and mean, maximal, and minimal FCT values can be obtained simultaneously. Boundary detection is performed with dynamic programming. 13, 14 This is a method that efficiently tries all paths between 2 points and selects the optimal one, ie, the path that optimizes a specified criterion. In our case, this criterion was a weighted sum of several terms. The first one rewards a vertically high-intensity gradient; this term is then weighted according to the method published by Liang et al. 13 The second term favors a smooth curve: if 2 horizontally adjacent points on the path have a large vertical separation, these points will be penalized by giving the cost term a higher value. The last 2 terms constrain the path to remain close to the manually marked restriction points. A point on the path lying horizontally close to but vertically far from a restriction point will be penalized. There are 2 terms for the restriction points because the vertical influence of the 2 extreme restriction points that define the length of the path is smaller than that of potential additional points set to guide the internal direction of the path.
Statistical Analyses
Agreement between ultrasound and histology for FCT values, interobserver agreement, and repeatability of the method were assessed by Bland-Altman analysis. Fisher exact test for dichotomous variables and 2-sample t test for continuous variables were used for the comparison of baseline characteristics between subjects with symptomatic and asymptomatic plaques. The Mann-Whitney test was used for comparison of FCT between the 2 groups. The accuracy of the method in discriminating symptomatic from asymptomatic plaques was assessed by receiver operating characteristic curves for the minimal, mean, and maximal FCT measurement. Bootstrap CIs were calculated for the cutoff points (decision FCT thresholds) that provided the best correct classification rates.
Results
The endarterectomy specimen of 1 patient unfortunately had undergone extensive surgical manipulation and was not judged appropriate by the pathologist for reliable assessment of the FC. In another patient, FC measurement was not possible because of intense calcifications with acoustic shadowing. Agreement between histology and ultrasound was excellent for the mean and maximal FCT and fair for the Steps of FCT measurement. A, Sonographer identifies CDFI frame that best depicts plaque with residual arterial lumen. B, Color is removed. On this high-resolution B-mode frame, concentric plaque with its FC can be identified on near (upper white frame) and far (lower white frame) arterial wall. C, Magnification of upper white frame (near wall). User defines 2 markers (red squares) that specify exact horizontal location of paths and approximate vertical location of FC. Blue line is interpolation between adjacent markers. Two boundaries are detected automatically: red line marks calculated transition from arterial lumen to FC, green line marks calculated transition from FC to lipid core. D, Magnification of lower white frame (far wall). Same procedure is repeated, but now green line is facing arterial lumen and red line is facing lipid core. Two additional restriction points were inserted manually to change direction of paths. minimal FCT; interobserver (GD versus OC) and intraobserver (GD) agreement for the method was very good (Table  1 ; Figure 3 ). Interobserver agreement between the technologist and GD and intraobserver agreement for the technologist was good (Table 1) .
We studied 62 ICA plaques (Sϭ23, ASϭ39) in 58 consecutive patients. After data processing, FCT evaluation was not possible in 4 patients (Sϭ1, ASϭ3) due to technical problems related to the morphology of the plaque ie, intense calcifications with acoustic shadows (2 cases) or FC too thin to measure (2 cases). Manual corrections with insertion of one to three additional restriction points were judged necessary in 32% of the cases. The baseline characteristics of the symptomatic and asymptomatic patients did not differ ( Table  2) . Twenty patients had an ischemic stroke, 1 had a hemispheric transient ischemic attack, and another had amaurosis fugax.
The obtained values of the minimal, mean, and maximal FCT for symptomatic and asymptomatic atheroma are depicted in Figure 4 . Symptomatic plaques had thinner FCs for 
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Discussion
There is growing evidence that the concept of "unstable" plaques is also applicable to carotid atheroma. The relative rarity of borderzone infarcts and the observation of emboli in the retina of patients with amaurosis fugax suggest that plaque rupture may play an important role in brain embolism. 15 Considerable attempts have been made to predict the occurrence of stroke by classifying carotid plaques according to their composition. Whether differences in plaque echogenicity or surface morphology can predict the clinical expression of atheroma is still debated. 11 Recent studies have shown that high-resolution MRI can visualize FCT and rupture in vivo. 10 However, the availability of this technique is currently very limited, and the data obtained are qualitative and not quantitative. 10 The present study shows that with the development of a semiautomated system to treat B-mode imaging, we can accurately measure the FCT of carotid plaques. The only 2 manual steps in the procedure are the selection of the CDFI frame to which automated FCT measurement will be applied and the selection of 2 points that specify the location of the paths plus additional restriction points in a third of the cases. This is not difficult for an experienced sonographer, although we must always bear in mind that ultrasound examination is observer dependent. The best compromise must take into consideration both the central and lateral parts of the FC. Caution must also be exercised when one deals with concentric stenoses, because the atheroma with its FC is often visible on both the near and far arterial walls ( Figure  2B ). The results of the present study suggest an encouraging correlation between FCT and the clinical expression of carotid atheroma. Symptomatic plaques had much thinner FCs than asymptomatic ones, and this held true regardless of the type of FCT measured (minimal, mean, or maximal). Mean FCT measurement discriminates symptomatic from asymptomatic atheroma well, although not perfectly, with a cutoff value of 0.65 mm attaining the best correct classification rate. The reason that minimal FCT performs the worst in terms of discrimination is that measured values are quite close to the axial resolution of the ultrasound instrument. This was also reflected in the inferior (yet sufficient) degree of agreement between histology and ultrasound for minimal FCT values compared with maximal and mean values.
Attempts to explore the surface of atheromatous carotid plaques with B-mode ultrasonography have already been made with relatively little success. 16 A recent interesting study comparing carotid endarterectomy specimens with preoperative carotid ultrasound results found that the best factors for characterization of carotid plaques were thinning and rupture of the FC 17 ; however, that study treated FCT as a dichotomous variable (thin: Ͻ1 mm, thick: Ͼ1 mm), did not focus on FCT measurement, and was performed with an ultrasound probe of 7.5 MHz.
The method of FTC measurement used in the present study has certain limitations. First, there is a contrast-resolution limitation in B-mode; even though modern ultrasound instruments have an axial resolution that ranges from 200 to 600 m, in a few cases, it is impossible to measure the FC, which is too thin. Similar difficulties are present for calcified or very fibrotic plaques, particularly in cases with complete acoustic shadowing. Second, there is a geometric-resolution limitation; at the moment, we measure structures with a size very close to or even smaller than the maximal resolution of the ultrasound instrumentation that we are using. We therefore run the risk that the FC will be melted together with the background or with other close structures. Ultrasound also has a tendency to shift toward the weaker echo side, 18 which, in the present case, would lead to an artificial enlargement of the FCT because the cap was surrounded by weaker echoes on either side of it (blood in the arterial lumen, and the lipid core). Thus, the FCT value that we measured may be an overestimation of the actual FCT; however, as shown by our validation study, agreement between ultrasound and histology was excellent for maximal and mean FCT, which confirms that the distance measured between the hypoechogenichyperechogenic and hyperechogenic-hypoechogenic interface actually corresponds to the FC.
Third, there are problems posed by acoustic anisotropy: the appearance of features will change depending on the angle of insonation, and tissue interfaces may not be well seen unless the ultrasound beam is perpendicular to the interface. Because we measured FCT on a single frame at the region of maximal lumen narrowing, we obtained far better visualization of the central part of the plaque than of its shoulder regions in Ϸ80% of our cases. One could state that plaques having caps that are thick over much of the necrotic core yet thinned (and perhaps prone to rupture) over the shoulder regions may have been misclassified as stable because of inadequate visualization of the distal and trailing ends of the plaque; however, in contrast to the coronaries, carotid plaque rupture appears to occur mostly at the midportion of the plaque rather than at the shoulder area. 7 Moreover, luminal surface changes have been shown to occur in the most severely stenotic regions of both symptomatic and asymptomatic carotid plaques, with surface irregularities being notably absent in areas of the plaque distant from the stenosis. 19 A 3D ultrasound technique would probably allow a thorough assessment of the cap. However, 3D ultrasound is not widely available; different techniques and transducers are still under development; it has a clearly inferior axial resolution compared with 2D ultrasound, which is crucial for FCT assessment; it cannot overcome acoustic shadowing and artifacts present in 2D images; and it is further limited by swallowing and respiration artifacts. 20 Our purpose was to develop an imaging method applicable to everyday practice and not another research tool with limited clinical applicability.
Fourth, the hypoechogenic structure just beneath the FC was presumed to be the lipid core of the plaque. The only other case in which a structure just beneath the plaque could appear hypoechogenic would be that of an intraplaque hemorrhage; however, what we are interested in is FC thinning, regardless of whether this is due to lipids or blood beneath the FC. Therefore, even if an intraplaque hemorrhage is misdiagnosed as a lipid pool, this does not preclude measurement of the FC as long as the cap is surrounded by hypoechogenic structures that permit accurate detection of its boundaries. In our histological study, we did not identify any cases of important intraplaque hemorrhage. The real problem lies in cases in which a carotid atheroma is highly calcified or fibrous, in which a hypoechogenic structure beneath the FC cannot be identified and therefore FC measurement is not possible. For these reasons, FC measurement was not possible in 1 (5%) of 22 plaques of the validation study and in 4 (6.5%) of 62 plaques of the second data set. At present, we cannot determine whether this percentage would be smaller or bigger in a larger or different series of patients.
Fifth, adherent thrombi in the ICA constitute a rare entity in patients with stroke and may have a different appearance on high-resolution B-mode imaging (ranging from hypoechogenic to hyperechogenic) depending on their consistency and age. 21 During ultrasound FCT measurements, we did not identify any patients with thrombi in our 2 data sets, and this was confirmed by histology in the validation set; however, ultrasound cannot exclude the presence of microaggregates of platelets and thrombin on the plaque surface, because these are well beyond the resolution of any existing ultrasound instrument. It is highly unlikely that these microaggregates, even if present, could have influenced the measurements. 
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Sixth, FCT values obtained by histology were on average slightly lower than those obtained by ultrasound, ranging from 1.0% for maximal FCT to 3.4% for minimal FCT (Table  1) . Tissue shrinkage during histological processing may account for this small discrepancy. Two studies comparing ultrasound and histology for intima-media thickness measurements in the common carotid artery reported average differences of 4% 22 and 14.6%. 23 In the former study, tissue shrinkage was only 2.5%. Our results are concordant with these studies. Although we did not account for tissue shrinkage, the agreement between ultrasound and histology was very good, which suggests that shrinkage was probably minimal. If considerable tissue shrinkage had occurred, a very good agreement between ultrasound and histology would have been possible only if ultrasound had systematically underestimated the actual FCT; however, as mentioned above, ultrasound tends to overestimate rather than underestimate FCT.
Hitherto, a semiautomated ultrasound system to quantify FCT and to investigate the clinical implications of this parameter in symptomatic and asymptomatic ICA atheromata has not been used. Our results are promising in terms of application to stroke prevention; however, additional studies to determine intrasonographer and intersonographer reproducibility are needed before the current technique can be used in clinical trials or in clinical practice. An ICA plaque with an FC thinner than 0.65 mm may help the clinician to identify patients with a higher risk of stroke. Nevertheless, only prospective population-based studies will determine the value of FCT, as evaluated by our method, for predicting the risk of subsequent brain ischemia.
